Percy Medicine Liquid
NDC Package 0322-2222-00
Package Information
Percy Medicine (bismuth subsalicylate) liquids is (shake well before using)Adults and children 12 yrs and over : 2 teaspoonfuls every hour as needed , not to exceed 4 doses in 24 hours and not more than 2 days.Children under 12: Consult a doctor. This formulation utilizes a liquid delivery system. Marketed by Merrick Medicine Company, Inc, this product is identified by NDC 0322-2222 and is authorized under FDA application M008.
Identification & Billing
- RxCUI: 1233767 - Percy Medicine 1050 MG in 10 mL Oral Supension
- RxCUI: 1233767 - bismuth subsalicylate 105 MG/ML Oral Suspension [Percy Medicine]
- RxCUI: 1233767 - Percy Medicine 105 MG/ML Oral Suspension
- RxCUI: 1233767 - Percy Medicine 1050 MG per 10 ML Oral Supension
- RxCUI: 616343 - bismuth subsalicylate 1050 MG in 10 mL Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0322 - Merrick Medicine Company, Inc
- 0322-2222 - Percy Medicine
- 0322-2222-00 - 1 BOTTLE in 1 BOX / 90 mL in 1 BOTTLE (0322-2222-03)
- 0322-2222 - Percy Medicine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0322-2222). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0322-2222-00 identifies a specific commercial package of 1 bottle in 1 box / 90 ml in 1 bottle (0322-2222-03) of Percy Medicine, a human over the counter drug labeled by Merrick Medicine Company, Inc. This liquid is formulated for oral use and contains bismuth subsalicylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Merrick Medicine Company, Inc on September 09, 2019. The current certification is valid through December 31, 2026.
How is this Merrick Medicine Company, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00322222200. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.